Clinical Implications of Various Criteria for the Biochemical Diagnosis of Insulinoma

다국어 초록 (Multilingual Abstract)

Background: Among the various diagnostic criteria for insulinoma, the ratio criteria have been controversial. However, the amended insulin-glucose ratio exhibited excellent diagnostic performance in a recent retrospective cohort study, although it has not yet been validated in other patient cohorts. We examined the diagnostic performance of the current criteria of the Endocrine Society, insulin-glucose ratio, C-peptide-glucose ratio, and amended ratios in terms of differentiating insulinomas.
Methods: We reviewed the medical records of patients who underwent evaluation for hypoglycemia from 2000 to 2013. Fourteen patients with histopathologically confirmed insulinoma and 18 patients without clinical evidence of insulinoma were included. The results of a prolonged fast test were analyzed according to the abovementioned criteria.
Results: Fulfilling all three Endocrine Society criteria—plasma levels of glucose (<3.0 mmol/L), insulin (≥18 pmol/L), and C-peptide (≥0.2 nmol/L)—exhibited 100% sensitivity and 89% specificity. Fulfilling the glucose and C-peptide criteria showed 100% sensitivity and 83% specificity, while fulfilling the glucose and insulin criteria showed 100% sensitivity and 72% specificity. Among the ratio criteria, the insulin-glucose ratio [>24.0 (pmol/L)/(mmol/L)] gave the highest area under the receiver operating characteristic curve, with 93% sensitivity and 94% specificity.
Conclusion: Fulfilling the glucose, insulin, and C-peptide criteria of the Endocrine Society guidelines exhibited the best diagnostic performance for insulinoma. Nonetheless, the insulin-glucose ratio may still have a role in the biochemical diagnosis of insulinoma.

참고문헌 (Reference)

1 Service FJ, "The prolonged fast" 85 : 3973-3974, 2000

2 Placzkowski KA, "Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007" 94 : 1069-1073, 2009

3 McAuley G, "Multimodality preoperative imaging of pancreatic insulinomas" 60 : 1039-1050, 2005

4 Grant CS, "Insulinoma" 19 : 783-798, 2005

5 Vezzosi D, "Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism" 157 : 75-83, 2007

6 Longo DL, "Harrison’s principles of internal medicine" McGraw-Hill 2012

7 Gardner DG, "Greenspan’s basic and clinical endocrinology" McGraw-Hill 2011

8 Cryer PE, "Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline" 94 : 709-728, 2009

9 Nauck MA, "Diagnostic accuracy of an “amended” insulin-glucose ratio for the biochemical diagnosis of insulinomas" 157 : 767-775, 2012

10 Turner RC, "Control of basal insulin secretion, with special reference to the diagnosis of insulinomas" 2 : 132-135, 1971

11 DeLong ER, "Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach" 44 : 837-845, 1988